Acetylator genotype (NAT2)-dependent formation of aberrant crypts in congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl

Cancer Research

Volumn 56, Issue 3, 1996, Pages 527-531

  Feng, Yi ^a   Wagner, Rick J ^a   Fretland, Adrian J ^a   Becker, William K ^a   Cooley, A Marvin ^a   Pretlow, Theresa P ^b   Lee, Kap J ^a   Hein, David W ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3 DIMETHYL 4 BIPHENYLAMINE; METHYLENE BLUE; PARAFORMALDEHYDE;

ACETYLATOR PHENOTYPE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; INTESTINE CRYPT; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RECTUM; SYRIAN HAMSTER;

ACETYLATION; AMINOBIPHENYL COMPOUNDS; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; COCARCINOGENESIS; COLONIC NEOPLASMS; CRICETINAE; FEMALE; GENOTYPE; MALE; MESOCRICETUS; PRECANCEROUS CONDITIONS;

EID: 0030040622     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Cancer Facts & Figures, 1995. American Cancer Society, Atlanta, GA.
2. Clayson, D. B., and Garner, R. C. Carcinogenic aromatic amines and related compounds. In: Charles E. Searle (ed), Chemical Carcinogens, ACS monograph 173, pp. 366-461. Washington, DC: American Chemical Society, 1976.
3. King, C. M., Romano, L. J., and Schuetzle, D. Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes New York: Elsevier, 1988.
4. Walpole, A. L., Williams, M. H. C., and Roberts, D. C. The carcinogenic action of 4-aminobiphenyl and 3,2′-dimethyl-4-aminobiphenyl. Br. J. Indust. Med. 9: 255-263, 1952.
5. Fiala, E. S., Weisburger, J. H., Katayama, S., Chandrasekaran, V., and Williams, G M. Effect of disulfiram on the carcinogenicity of 3,2′-dimethyl-4-aminobiphenyl in Syrian golden hamsters and rats Carcinogenesis (Lond.), 20: 965-969, 1981
6. Williams, G. M., Chandrasekaran, V., Katayama, S., and Weisburger, J. H. Carcinogenicity of 3-methyl-2-naphthylamine and 3,2′-dimethyl-4-aminobiphenyl to the bladder and gastrointestinal tract of the Syrian golden hamster with atypical proliferative enteritis. J. Natl. Cancer Inst., 67: 481-488, 1981.
7. Nussbaum, M., Fiala, E. S., Kulkarni, B., El-Bayoumy, E. S., and Weisburger, J H In vivo metabolism of 3,2′-dimethyl-4-ammobiphenyl (DMAB) bearing on its organotropism in the Syrian golden hamster and the rat. Environ. Health Perspect., 49: 223-231, 1983
8. PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylatioa of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci USA, 86: 7696-7700, 1989.
9. Lang, N P., and Kadlubar, F F. Aromatic and heterocyclic amine metabolism and phenotyping in humans. In. B Glendhill and F. Mauro (eds), New Horizons in Biological Dosimetry, pp. 34-47. Wiley-Liss: New York, 1991.
10. Flammang, T. J., and Kadlubar, F. F. Acetyl-CoA-dependent metabolic activation of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxyarylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acetyltransferases. Carcinogenesis (Lond), 7. 919-926, 1986
11. Ogolla, F, Ferguson, R. J., Kirlin, W. G., Trinidad, A., Andrews, A. F., Mpezo, M, and Hein, D. W. Acetylator genotype-dependent expression of arylamine N-acetyl-transferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon, identity with the hepatic acetylation polymorphism. Drug Metab. Dispos., 18: 680-685, 1990
12. Turesky, R H., Lang, N. P., Butler, M. A., Teitel, C. H., and Kadlubar, F F Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis (Lond.), 12: 1839-1845, 1991.
13. Hein, D W., Doll, M. A., Gray, K., Rustan, T. D., and Ferguson, R. J. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res., 53: 509-514, 1993.
14. Hein, D. W. Acetylator genotype and arylamine-induced carcinogenesis Biochim Biophys. Acta, 948: 37-66, 1988.
15. Weber, W W., and Hein, D W. N-Acetylation pharmacogenetics. Pharmacol. Rev., 37 25-79, 1985.
16. Kadlubar, F. F., Butler, M. A. Kaderlik, K. R , Chou, H C , and Lang, N C Polymorphisms for aromatic amine metabolism in humans, relevance for human carcinogenesis. Environ Health Perspect., 98: 69-74, 1992.
17. Grant, D. M Molecular genetics of the N-acetyltransferases. Pharmacogenetics, 3 45-50, 1993.
18. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J-M., Evans, D A P., Grant, D M., Hein, D. W , Lin, H J., Meyer, U. A., Relling, M. V , Sim, E , Suzuki, T , and Yamazoe, Y Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17, 1995
19. Lang, N. P., Chu, D Z., Hunter, C. F., Kendall, D C., Flammang, T. J., and Kadlubar, F. F. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg., 121: 1259-1261, 1986.
20. Ilett, K. F., David, B. M., Dethon, P., Castleden, W. M , and Kwa, R. Acetylator phenotype in colorectal carcinoma. Cancer Res., 47. 1466-1469, 1987.
21. Minchin, R. F., Kadlubar, F F., and Ilett, K. F. Role of acetylation in colorectal cancer Mutat. Res., 290: 35-42, 1993.
22. Lang, N. P., Butler, M A., Massengell, J., Lawson, M., Stotts, R. C., Hauer-Jensen, M., and Kadlubar, F. F. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increases the risk for colorectal cancer or polyps. Cancer Epidemiol., Biomarkers & Prev., 3: 675-682, 1994.
23. Kirlin, W. G., Ogolla, F., Andrews, A. F., Trinidad, A., Ferguson, R. J., Yerokun, T., Mpezo, M., and Hein, D. W. Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients. Cancer Res , 51: 549-555, 1991.
24. Ladero, J. M., Gonzalez, J. F., Benitez, J , Vargas, E., Fernandez, M. J., Baki, W., and Diaz-Rubio, M. Acetylator polymorphism in human colorectal carcinoma. Cancer Res., 51: 2098-2100, 1991.
25. Rodriguez, J. W., Kirlin, W. G., Ferguson, R. J. Doll, M. A., Gray, K., Rustan, T. D., Lee, M. E., Kemp, K., Urso, P., and Hein, D W. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol. Arch. Toxicol., 67: 445-452, 1993.
26. Probst-Hensch, N. M., Haile, R W , Ingles, S. A., Longnecker, M. P., Han, C. Y., Lin, B. K., Lee, D. B., Sakamoto, G. T., Franskl, H D., Lee, E. R., and Lin, H. J. Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res., 55: 2017-2020, 1995
27. Hein, D. W. A new model for toxic risk assessments: construction of homozygous rapid and slow acetylator congenic Syrian hamster lines. Toxicol Methods, 1: 44-52, 1991
28. Ferguson, R. J., Doll, M. A., Baumstark, B. R., and Hein, D. W. Polymorphic arylamine-N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene (Amst), 140: 247-249, 1994
29. Ferguson, R. J., Doll, M. A., Rustan, T. D., and Hein, D. W Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster. Pharmacogenetics, 5: in press, 1995.
30. Feng, Y., Rustan, T. D , Ferguson, R. J., Doll, M. A., and Hein, D. W Acetylator genotype-dependent formation of 2-aminofluorene-hemoglobin adducts in rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. Toxicol. Appl. Pharmacol., 124: 10-15, 1994.
31. Hein, D. W., Rustan, T. D , Bucher, K. D., and Miller, L. S. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. J. Pharmacol. Exp. Ther., 259: 699-704, 1991.
32. Hein, D. W., Rustan, T. D , Martin, W. J., Bucher, K. D., Miller, L. S , and Furman, E. J. Acetylator genotype-dependent N-acetylation of arylamines in vivo and in vitro by hepatic and extrahepatic organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus Arch. Toxicol., 66: 112-117, 1992.
33. Bird, R. R. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer. Lett., 37: 147-151, 1987.
34. Pretlow, T. P., O'Riordan, M. A , Somich, G. A., Amini, S. B., and Pretlow, T. G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis (Lond.), 13: 1509-1512, 1992.
35. McLellan, E. A., and Bird, R. P Aberrant crypts: potential preneoplastic lesions in the murine colon Cancer Res., 48. 6187-6192, 1988.
36. Tudek, B., Bird, R P , and Bruce, W. R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with food. Cancer Res , 49: 1236-1240, 1989.
37. Pretlow, T P. Alterations associated with early neoplasia in the colon. In: T. G. Pretlow and T. P Pretlow (eds.), Biochemical and Molecular Aspects of Selected Cancers, Vol. 2, pp 93-141 San Diego: Academic Press, 1994.
38. McLellan, E A., and Bird, R. P. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res., 48: 6183-6186, 1988.
39. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Turcisek, J. A., and Stellato, T A. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51: 1564-1567, 1991.
40. Roncucci, L., Medline, A., and Bruce, W. R. Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol., Biomarkers & Prev , 1: 57-60, 1991.
41. McLellan, E. A , Medline, A., and Bird, R. P. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis (Lond.), 12: 2093-2098, 1991.
42. Roncucci, L., Pedroni, M., Fante, R., Gregorio, C. D., and Ponz de Leon, M. Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res., 53: 3726-3729, 1993.
43. Pretlow, T P., Cheyer, C., and O'Riordan, M. A. Aberrant crypt foci and colon tumors in F344 rats bave similar increases in proliferative activity. Int. J. Cancer, 56: 599-602, 1994.
44. Stopera, S. A., Davie, J. R., and Bird, R. P. Clonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer. Carcinogenesis (Lond.), 13: 573-578, 1992.
45. Stopera, S. A., and Bird, R. P. Expression of ras oncogene mRNA and protein in aberrant crypt foci. Carcinogenesis (Lond.), 13: 1863-1868, 1992.
46. Pretlow, T. P., Roukhadze, E. V., O'Riordan, M. A., Chen, J. C., Amini, S. B., and Stellato, T. A. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology, 107: 1719-1725, 1994.
47. Zaidi, N. H., Pretlow, T. P., O'Riordan, M. A., Dumenco, L. L., Allay, E., and Gerson, S L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon Carcinogenesis (Lond.), 16: 451-456, 1995.
48. Stopera, S. A., Murphy, L. C., and Bird, R. P Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer Carcinogenesis (Lond.), 13: 2081-2085, 1992.
49. Shivapurkar, N., Tang, Z., Ferreira, A., Zasim, S., Garett, C., and Alabaster, O. Sequential analysis of K-ras mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in Fisher-344 rats on high-risk diet. Carcinogenesis (Lond.), 15: 775-778, 1994.
50. Pretlow, T. P., Brasitus, T. A., Fulton, N. C , Cheyer, C., and Kaplan, E. L. K-ras mutations in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst., 85. 2004-2007, 1993.
51. Jen, J., Powell, S. M., Papadopoulos, N., Smith, K. J , Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54: 5523-5526, 1994.
52. Smith, A. J., Stern, H. S., Penner, M., Hay, K., Mitri, A., Bapat, B. V., and Gallinger, S, Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54: 5527-5530, 1994
53. Yamashita, N., Minamoto, T., Ochiai, A., Onda, M., and Esumi, H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon Gastroenterology, 108: 434-440, 1995.
54. Lam, L. K., and Zhang, J. Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents. Carcinogenesis (Lond.), 12: 2311-2315, 1991.
55. Ilett, K. F., Ingram, D. M., Carpenter, D. S , Teitel, C. H., Lang, N. P., Kadlubar, F. F , and Minchin, R F Expression of monomorphic and polymorphic N-acetyltransferases in human colon Biochem. Pharmacol., 47: 914-917, 1994
56. Ferguson, R. J. Doll, M A., Rustan, T. D., Baumstark, B. R , and Hein, D. W. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics, 4, 82-90, 1994.
57. Feng, Y., Cooley, M. A., Lee, K. H., Becker, W K , Pretlow, T. P., and Hein, D W. Aberrant crypts in colonic mucosa of homozygous rapid and slow acetylator congenic Syrian hamsters administered 3,2′-dimethyl-4-aminobiphenyl. Proc Am. Assoc. Cancer Res., 36: 130, 1995.
58. Feng, Y., Fretland, A. J., Wagner, R J., Martin, W. J., Rustan, T. A., Cooley, A. M., Lee, K J., Becker, W. K., and Hein, D. W. 3,2′-Dimethyl-4-aminobiphenyl-induced aberrant crypts in homozygous rapid and slow acetylator Syrian hamsters congenic at the NAT2 locus. Proceedings of the Sixth International Conference on Carcinogenic and Mutagenic N-Substituted Aryl Compounds, p. 64. Monterey, CA, November 1995.